New solution helps engage the right stakeholders globally across all
channels
PLEASANTON, Calif.--(BUSINESS WIRE)--
At its European Commercial Summit today, Veeva Systems unveiled Veeva
Medical CRM, a cloud-based solution that enables key opinion leader
(KOL) visibility and improved engagement. Armed with the right
information aligned to interests and product lifecycle needs, field
medical teams can drive informed scientific interactions and build
deeper, more trusted stakeholder relationships.
The number of medical science liaisons (MSLs) is expected to grow
globally by 20% over the next two years, according to a 2015 study by MSL
Insights.1 This MSL growth, largely driven by the rise of
complex drug products, reflects the increasing need by healthcare
professionals for more specialized knowledge and product information.
However, hindered by dozens of systems, MSLs struggle to quickly and
accurately identify, profile, and engage KOLs. Veeva solves the problem
with a solution designed to enable better stakeholder planning and
engagement.
With Veeva Medical CRM’s full KOL view and multichannel engagement, MSLs
can deliver personalized information at each stage of a drug’s life,
through the right channel – creating a more valuable KOL experience. The
solution interoperates with Veeva
KOL Data, which delivers a consolidated feed of up-to-date
information and unique insights on KOLs worldwide. At a glance, MSLs see
a complete picture of KOLs, their preferences, relationship networks,
and affiliations with healthcare organizations like integrated delivery
networks (IDNs), payers, and pharmacy and therapeutics (P&T) committees.
With this visibility, MSLs can more effectively engage KOLs across all
channels. And, as an open solution, Veeva Medical CRM can manage any
internal or third-party KOL data sources.
“Traditionally, medical teams have struggled with multiple, disparate
systems, limiting their ability to engage stakeholders and to quantify
the effectiveness of their efforts,” said Robert Groebel, Veeva’s vice
president of global medical strategy. “As the role of medical affairs
grows, teams are seeking new metrics, both quantitative and qualitative,
to show the value of these interactions. With Veeva Medical CRM, medical
affairs gains real-time visibility into its impact across channels –
demonstrating medical’s strategic value and supporting continuous
process improvement.”
Veeva Medical CRM works seamlessly with Veeva CRM, allowing for
controlled collaboration and information sharing between medical and
commercial teams, enabling a more coordinated customer experience.
Veeva Medical CRM is now available globally.
In other news today, Veeva announced the global availability of Veeva
KOL Data as a subscription, offering a single consolidated,
global source of all key stakeholder information. Additionally, Veeva
announced the availability of Veeva
CRM Suggestions, which leverages the power of data science to
correlate large quantities of data with actual customer behaviors to
recommend next best actions to take across which channels.
Additional Information
To learn more about Veeva’s new solution for medical teams, visit: veeva.com/medical
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 375 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended July 31, 2015. This is available on the
company’s website at http://www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
1. MSL Insights, A Global Survey Reveals: The Medical Science
Liaison competencies that contribute most to success, Medical Science
Liaison Society, July 2015.
® 2015 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo
are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other
registered and unregistered trademarks.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151203005512/en/
Source: Veeva Systems Inc.